FDA inspection
Fibrocell Technologies, Inc.: FDA inspection ending May 21, 2019
FDA inspection 1092596 · No Action Indicated (NAI) · Exton, PA
Key facts
| Inspection ID | 1092596 |
|---|---|
| Firm | Fibrocell Technologies, Inc. |
| FEI number | 3005836954 |
| Address | 405 Eagleview Blvd |
| City | Exton |
| State | PA |
| ZIP | 19341 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | May 21, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data